FREDERICK CHUA
ORANGE, CA
Browse related groups: CA Alnylam Pharmaceuticals Inc. All categories
This page merges CMS profile IDs: 11309857, 8807595 (associated profiles published by CMS for the same provider; see the provenance section below).
General Payments — all program years on this page
$298.23
- Category: General Payments
- Program years: PY2020–2023
- Record count: 11
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $250.21 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $250.21 | 8 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | $96.89 | 1 |
| Otsuka America Pharmaceutical, Inc. | $47.61 | 2 |
| GlaxoSmithKline, LLC. | $40.58 | 2 |
| ABIOMED | $29.95 | 1 |
| Lilly USA, LLC | $20.37 | 1 |
| Merck Sharp & Dohme Corporation | $14.81 | 1 |
By program year
Records — PY2023 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1002893163 | GlaxoSmithKline, LLC. | $27.88 | 10/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1002893173 | GlaxoSmithKline, LLC. | $12.70 | 04/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1006149495 | Alnylam Pharmaceuticals Inc. | $96.89 | 10/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1014277391 | Otsuka America Pharmaceutical, Inc. | $24.34 | 09/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1014277399 | Otsuka America Pharmaceutical, Inc. | $23.27 | 11/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1031422359 | Lilly USA, LLC | $20.37 | 09/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1044833151 | ABIOMED | $29.95 | 10/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1048726701 | Merck Sharp & Dohme LLC | $14.81 | 11/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
- Merged CMS profile IDs: 11309857, 8807595
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.